Lincomycin hydrochloride monohydrate is a lincosamide antibiotic derived from Streptomyces lincolnensis, primarily indicated for the treatment of serious infections caused by susceptible staphylococcal,… Read more
Lincomycin hydrochloride monohydrate is a lincosamide antibiotic derived from Streptomyces lincolnensis, primarily indicated for the treatment of serious infections caused by susceptible staphylococcal, streptococcal, and Bacteroides fragilis strains. This category provides comprehensive analytical tools required for the rigorous evaluation of this pharmaceutical agent. Laboratories utilize these high-quality reference standards for impurity profiling and method validation to ensure compliance with pharmacopeial requirements. By incorporating both pharmacopeial and non-pharmacopeial impurities, these products facilitate accurate identification and quantification during routine quality control procedures. Additionally, stable isotope-labelled compounds are included to serve as internal standards for mass spectrometry-based assays, enabling precise quantitation in complex matrices. Accessing this full spectrum of related compounds allows researchers to maintain strict regulatory standards and verify the purity and stability of lincomycin formulations throughout the pharmaceutical development and manufacturing process.